Richard Ambinder

Medicine & Life Sciences

1. Human Herpesvirus 4 100%
2. Hodgkin Disease 71%
3. Cyclophosphamide 49%
4. Lymphoma 39%
5. Non-Hodgkin's Lymphoma 36%
6. HIV 36%
7. Bone Marrow 33%
8. Bone Marrow Transplantation 33%
9. Graft vs Host Disease 32%
10. Transplantation 31%
11. Transplants 29%
12. Neoplasms 26%
13. Human Herpesvirus 8 26%
14. Rituximab 25%
15. Acquired Immunodeficiency Syndrome 24%
16. Kaposi's Sarcoma 20%
17. Homologous Transplantation 20%
18. AIDS-Related Lymphoma 20%
19. Haploidentical Transplantation 19%
20. Methylation 17%
21. Tissue Donors 17%
22. Herpesviridae 16%
23. DNA 16%
24. Progression-Free Survival 14%
25. Burkitt Lymphoma 14%
26. B-Lymphocytes 14%
27. Drug Therapy 14%
28. Survival 14%
29. T-Lymphocytes 13%
30. Therapeutics 13%
31. B-Cell Lymphoma 12%
32. Epstein-Barr Virus Infections 12%
33. Hematologic Neoplasms 11%
34. Viruses 11%
35. Confidence Intervals 10%
36. Recurrence 10%
37. Epigenomics 9%
38. Primary Effusion Lymphoma 8%
39. Gene Expression 8%
40. Cell Line 8%
41. Central Nervous System 8%
42. Virus Latency 8%
43. In Situ Hybridization 8%
44. Nasopharyngeal Carcinoma 8%
45. Viral Genes 7%
46. Ganciclovir 7%
47. Busulfan 7%
48. Cell Transplantation 7%
49. trans-crotonin 7%
50. Lymphoproliferative Disorders 6%